Original Article

Pregnancy Loss after First Trimester Viability in Women with Sickle Cell Trait: A Preliminary Report

Authors: Michelle Y. Taylor, MD, Josephine Wyatt-Ashmead, MD, Jermaine Gray, MD, James A. Bofill, MD, Rick W. Martin, MD, John C. Morrison, MD

Abstract

Background: Traditionally, sickle cell trait has not been associated with a higher risk of fetal death, but we noted several, which led us to assess all such pregnancies.


Methods: In this retrospective study, 131 patients with sickle cell trait were analyzed over a two-year period. The Institutional Review Board approved the collection of deidentified data.


Results: Subjects were African-American with an average age of 23.9 years, and average gestational age at delivery of 30.1 weeks. There were 10 (8.13%) intrauterine fetal deaths (IUFDs), and one neonatal death. Ascending amniotic fluid infection was noted in 50% and 92% meconium histocytes. All placentas had sickling in the intervillous space and the decidual vessels.


Conclusions: Sickling in the decidual vessels and poor placental perfusion may play a role in pregnancy loss in excess of what has previously been reported. A cohort control study appears to be in order.


Narrative: Pregnant women with sickle cell trait are thought not to have increased maternal or fetal mortality/morbidity. Over a two year period, we studied 131 women with this hemoglobinopathy and found that 10.6% had intrauterine growth retardation (IUGR), 8.4% preterm premature rupture of the membranes, 8.1% intrauterine fetal demise (n = 10) at most occurring at 16 to 24 weeks, and one neonatal death. Amniotic fluid infection was noted in 50%, and meconium histocytes indicating intrauterine hypoxia were noted, as was unsuspected sickling in the placental vasculature. Based on this case series, sickle cell trait may not be as benign for the fetus as was previously thought.


Key Points


* Among 131 gestations complicated by sickle trait, 10.6% had intrauterine growth retardation (IUGR), 8.4% experienced preterm premature rupture of the membranes, 16% had hypertensive disorders of pregnancy and 10 (8.1%) who had intrauterine fetal demise with one neonatal death.


* Most of the fetal demises occurred early (16–24 weeks) and there was evidence of acute ascending amniotic fluid infection in half of the specimens, while meconium histocytosis indicating intrauterine hypoxia was present in 92%.


* Sickled cells are expected in such patients in the intervillous space, but surprisingly, sickling also occurred in the placental vasculature and decidual vessels.


* Sickle cell trait in pregnancy may not be as benign for the fetus as previously thought.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. American College of Obstetrics and Gynecology. Hemoglobinopathies in Pregnancy. Washington, DC; July 2005 Practice Bulletin No. 64.
 
2. Baill I, Witter F. Sickle cell trait and its association with birth weight and urinary tract infections in pregnancy. International Journal of Gynecology and Obstetrics 1990;33:19–21.
 
3. Altshuler G. A conceptual approach to placental pathology and pregnancy outcome. Seminars in Diagnostic Pathology 1993;10:204–221.